PainTEQ Welcomes Robert Kline to Enhance Spine Care Standards

Author: Olivia Taylor Updated: 10-28-2025 05:25 AM

PainTEQ Welcomes Robert Kline to the Board

In an exciting development, Med-tech veteran Robert Kline has joined the Board of Directors at PainTEQ. This strategic addition marks a significant step as the company seeks to redefine interventional spine care. With over 25 years of experience in commercializing cutting-edge medical devices, Kline is set to play a crucial role in enhancing PainTEQ's market position.

Robert Kline's Extensive Experience

Kline is no stranger to the med-tech space, having founded Medivance, which led the way in therapeutic temperature management. His company was successfully acquired by C. R. Bard in 2011. Additionally, he co-founded ViroCyt, later purchased by Sartorius AG in 2016. Kline also served as the CEO of Bolder Surgical, a company that was acquired by Hologic, Inc. for an impressive $160 million.

Strategic Expansion with LinQ System

With Kline's strategic insights, PainTEQ is poised to accelerate the growth and adoption of its flagship LinQ system, which has already benefitted over 14,000 patients. The LinQ SI Joint Stabilization System is designed to offer a minimally invasive procedure, enabling quicker recoveries and reduced tissue damage compared to traditional surgeries. Robert Kline believes in the system's efficacy, stating, "The LinQ system works. It provides superior patient outcomes in a highly efficient manner—the gold standard for med-tech innovation."

Vision for Clinical Excellence

PainTEQ's CEO, Shanth Thiyagalingam, emphasized the importance of Kline's expertise in driving clinical excellence and advancing the company’s mission. With his guidance, PainTEQ aims to accelerate its responsible adoption in clinical settings and elevate overall standards of care.

About PainTEQ

PainTEQ is dedicated to revolutionizing interventional spine care by working closely with pain management specialists. Their goal is to reduce and eliminate sacroiliac joint dysfunction, which is often a source of debilitating lower back pain for many. The LinQ implant, along with its single-use instruments, aims to provide immediate clinical benefits through minimally invasive outpatient procedures.

Innovative Solutions for Pain Management

PainTEQ's LinQ system offers an effective alternative to more invasive surgery. By utilizing a single-implant approach, it significantly reduces procedure time and enhances recovery, paving the way for patients to swiftly return to their daily activities.

Commitment to Patient Care

With a clear focus on patient outcomes, PainTEQ remains committed to delivering innovative solutions for those suffering from chronic pain. This promise is further supported by an ongoing dedication to evidence-backed medicine and clinical excellence.

Frequently Asked Questions

1. What is PainTEQ's main focus?

PainTEQ focuses on interventional procedures aimed at reducing and eliminating sacroiliac joint dysfunction to improve patient outcomes.

2. Who is Robert Kline?

Robert Kline is a seasoned med-tech professional who has joined PainTEQ's Board of Directors to enhance the company's strategic direction.

3. What is the LinQ system?

The LinQ SI Joint Stabilization System is a minimally invasive approach designed for treating pain associated with sacroiliac disease.

4. How has the LinQ system performed?

The LinQ system has provided relief in over 14,000 procedures, showcasing its efficacy and success in clinical applications.

5. Why is Kline's addition important?

Kline's vast experience in the med-tech industry and history of successful commercialization positions PainTEQ for accelerated growth and adoption of its innovative solutions.

About The Author

Olivia Taylor here, a 26-year-old writer and financial advisor. After earning a degree in finance, I worked in the sector for years. I've always loved numbers and had a talent for simplifying difficult financial ideas so that anyone could understand. I wrote my first book because of this passion; it helps readers take charge of their financial futures by fusing real-life stories with useful financial advice.

Whether they are just beginning their careers, preparing for significant life events, or seeking to invest wisely, my goal with my writing is to enable people to make educated financial decisions. The foundation of my work is the conviction that security and freedom of the individual are largely determined by financial literacy. To further financial education, I run workshops and frequently write for financial blogs in addition to my books.

I like to travel, experience other cultures, and find inspiration in daily life when I'm not writing or examining market trends. My passion is utilizing sound financial practices to help people reach their financial objectives and lead the best lives possible.

Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.